NEOSAR Drug Patent Profile
✉ Email this page to a colleague
When do Neosar patents expire, and what generic alternatives are available?
Neosar is a drug marketed by Bedford and Teva Parenteral and is included in two NDAs.
The generic ingredient in NEOSAR is cyclophosphamide. There are nineteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Neosar
A generic version of NEOSAR was approved as cyclophosphamide by BAXTER HLTHCARE on May 21st, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEOSAR?
- What are the global sales for NEOSAR?
- What is Average Wholesale Price for NEOSAR?
Summary for NEOSAR
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 95 |
| Clinical Trials: | 420 |
| Patent Applications: | 4,454 |
| DailyMed Link: | NEOSAR at DailyMed |
Recent Clinical Trials for NEOSAR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Southern California | Phase 1 |
| Fred Hutchinson Cancer Center | Phase 2 |
| National Cord Blood Network | Phase 2 |
US Patents and Regulatory Information for NEOSAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bedford | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 087442-004 | Jul 8, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Parenteral | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 040015-005 | Apr 29, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bedford | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 087442-002 | Feb 16, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva Parenteral | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 040015-001 | Apr 29, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bedford | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 087442-005 | Mar 30, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bedford | NEOSAR | cyclophosphamide | INJECTABLE;INJECTION | 087442-001 | Feb 16, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
